Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Study size
"If newly identified safety signals are identified, the FDA will determine what, if any, actions are appropriate after a thorough review of available data." These actions may include requiring labeling changes or development of a Risk Evaluation and Mitigation Strategy, a program that helps ensure a medication's benefits outweigh its risks
10.12659/msm.903855 50 DuanZ.LuoY
This option addresses several aspects of the underlying pathophysiology of T2D, and has the potential to offer effective glycemic control with less hypoglycemia and no weight gain compared to basal insulin therapy [4, 5]
US$ 20.40
US$ 27.06
US$ 29.30
US$ 27.42
US$ 26.74
US$ 21.06
US$ 28.12
